This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

DATATRAK Participates In March Industry Events

Stocks in this article: DATA

CLEVELAND, March 4, 2013 /PRNewswire/ -- D ATATRAK International, Inc. (OTCQX: DATA), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced its participation at industry events during the month of March.

(Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)

25 th Annual EuroMeeting RAI, Amsterdam, The Netherlands March 4-6, 2013Booth #840

Dr. Bill Gluck, D ATATRAK's VP of Clinical and Consulting Services, is chairing the session Adoption Of Game Changing Technologies on Wednesday, March 6 from 11:00AM - 12:30PM.

D ATATRAK is exhibiting at the DIA's Annual EuroMeeting, which attracts well over 3,000 professionals from more than 50 countries from the biopharmaceutical industry, contract research and service organisations, academic research centres, regulatory agencies and health ministries as well as patient organisations. This convergence affords participants the opportunity to network with professional colleagues from around the world.  For more information, visit www.diahome.org.

HIMSS 13 Annual Conference and Exhibition New Orleans, LA March 3-7, 2013

D ATATRAK is attending the HIMSS 13 Annual Conference and Exhibition to ensure our teams have the opportunity to discuss the latest advances in leveraging technology, current regulatory mandates and quality policies.  The week-long conference includes more than 1100 world class exhibitors and covers topics such as Meaningful Use, ICD-10/HIPAA 5010 compliance, Affordable Care Act, EHR and Heath IT Issues. For more information on the conference, see http://www.himssconference.org.

CBI ClinTech (CTMS, eTMF, Portal, EDC) Philadelphia, PA March 11-13, 2013

Chris Wilke, Chief Technology Officer of D ATATRAK, presents a case study during the Clinical System Integrations Operational Strategies and Technical Blueprints to Achieve Interoperability of CTMS, EDC, Quality Risk Management Systems and IVRS session on Monday, March 11, 2013 at 2:45PM.

DATATRAK is sponsoring, exhibiting and presenting at the ClinTech 2013 Conference – Implement, Manage and Integrate Systems to Advance Clinical Trials.  Learn more about the latest applications and strategies to meet today's clinical demands, including a Cloud Seminar to discuss the benefits of Cloud hosting.  To learn more about this CBI hosted event, see www.cbinet.com.

ACDM Conference (Association for Clinical Data Management)Wokefield Park, Berkshire, UK March 17-19

William Gluck, PhD, will be presenting the session Using Technology to Integrate Clinical Data Management and Clinical Operations on Monday, March 18 th at 3:20PM.

D ATATRAK will be exhibiting and speaking at the ACDM Annual Conference 2013, which brings together all levels of staff from Data Management departments in the major biopharmaceutical companies and Clinical research organizations.  The ACDM Conference provides an environment to discuss standards as well as enhance individual skills, knowledge and professional development of its members. See www.acdm.org.uk for more information.

About D ATATRAK

D ATATRAK is the leader of unified eClinical® technologies and related services for the clinical trials industry.  Using the D ATATRAK ONE™ multi-product, cloud-based clinical research platform, D ATATRAK 's Clinical and Consulting Services™ group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. D ATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements.  For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 14, 2012 announcing its results for the three-month period ending September 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,390.52 +195.10 1.13%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,630.7410 +64.6030 1.41%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs